Just Released: "Peru Pharmaceuticals & Healthcare Report Q2 2013"
Strong economic growth, the business-friendly operating environment and increasing domestic demand in Peru will provide revenue-earning opportunities for multinational pharmaceutical and healthcare companies. The potential local currency depreciation in the medium term will also benefit companies using Peru as a production hub to export to neighbouring countries. The strict regulatory standards in Peru are also to the advantage of multinationals, which can leverage their industrial expertise in production and reduce competition from local companies. However, challenges – in the form...
View full press release